Recombinant Human TNF-alpha Hyperactive Mutant Protein Summary
Additional Information |
Mutant form with approximately 5-fold greater activity |
Details of Functionality |
Measured in a cytotoxicity assay using L‑929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. Matthews, N. and M.L. Neale (1987) in Lymphokines and Interferons, A Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 221. The ED50 for this effect is 2.5-12.5 pg/mL. |
Source |
E. coli-derived human TNF-alpha protein Lys87-Leu233 (Leu233Phe), with an N-terminal Met-Arg-Lys-Arg |
Accession # |
|
N-terminal Sequence |
Met |
Structure / Form |
Non-covalent trimer |
Protein/Peptide Type |
Recombinant Proteins |
Gene |
TNF |
Purity |
>95%, by SDS-PAGE with silver staining. |
Endotoxin Note |
<0.10 EU per 1 μg of the protein by the LAL method. |
Applications/Dilutions
Dilutions |
|
Theoretical MW |
17 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
SDS-PAGE |
16 kDa, reducing conditions |
Packaging, Storage & Formulations
Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 3 months, -20 to -70 °C under sterile conditions after reconstitution.
|
Buffer |
Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Purity |
>95%, by SDS-PAGE with silver staining. |
Reconstitution Instructions |
Reconstitute at 100 μg/mL in PBS. |
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human TNF-alpha Hyperactive Mutant Protein
Background
Tumor necrosis factor alpha (TNF-alpha ), also known as cachectin and TNFSF1A, is the prototypic ligand of the TNF superfamily. It is a pleiotropic molecule that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism (1, 2). Human TNF-alpha consisits of a 35 amino acid (aa) cytoplasmic domain, a 21 aa transmembrane segment, and a 177 aa extracellular domain (ECD) (3). Within the ECD, human TNF-alpha shares 97% aa sequence identity with rhesus and 71%-92% with bovine, canine, cotton rat, equine, feline, mouse, porcine, and rat TNF-alpha . TNF-alpha is produced by a wide variety of immune, epithelial, endothelial, and tumor cells (1, 2). TNF-alpha is assembled intracellularly to form a noncovalently linked homotrimer which is expressed on the cell surface (4). Cell surface TNF-alpha can induce the lysis of neighboring tumor cells and virus infected cells, and it can generate its own downstream cell signaling following ligation by soluble TNFR I (2, 5). Shedding of membrane bound TNF-alpha by TACE/ADAM17 releases the bioactive cytokine, a 55 kDa soluble trimer of the TNF-alpha extracellular domain (6-8). TNF-alpha binds the ubiquitous 55-60 kDa TNF RI (9, 10) and the hematopoietic cell-restricted 80 kDa TNF RII (11, 12), both of which are also expressed as homotrimers (1, 2, 13). Both type I and type II receptors bind TNF-alpha with comparable affinity (14), although only TNF RI contains a cytoplasmic death domain which triggers the activation of apoptosis. Soluble forms of both types of receptors are released and can neutralize the biological activity of TNF-alpha (15). This recombinant protein contains an N-terminal insertion and a Leu233Phe substitution which have been shown to increase the bioactivity of TNF-alpha
in vitro and
in vivo (16).
- Zelova, H. and J. Hosek (2013) Inflamm. Res. 62:641.
- Juhasz, K. et al. (2013) Expert Rev. Clin. Immunol. 9:335.
- Pennica, D. et al. (1984) Nature 312:724.
- Tang, P. et al. (1996) Biochemistry 35:8216.
- Perez, C. et al. (1990) Cell 63:251.
- Black, R.A. et al. (1997) Nature 385:729.
- Moss, M.L. et al. (1997) Nature 385:733.
- Gearing, A.J.H. et al. (1994) Nature 370:555.
- Schall, T.J. et al. (1990) Cell 61:361.
- Loetscher, H. et al. (1990) Cell 61:351.
- Dembic, Z. et al. (1990) Cytokine 2:231.
- Smith, C.A. et al. (1990) Science 248:1019.
- Loetscher, H. et al. (1991) J. Biol. Chem. 266:18324.
- Pinckard, J.K. et al. (1997) J. Biol. Chem. 272:10784.
- Engelmann, H. et al. (1990) J. Biol. Chem. 265:1531.
- Yan, Z. et al. (2006) Cytotherapy 8:415.
Customers Who Viewed This Item Also Viewed...
Species: Mu
Applications: ELISA
Species: Mu
Applications: ELISA
Species: Mu
Applications: ELISA
Species: Mu
Applications: ELISA
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Hu, Rb, Rt
Applications: Flow, IHC, IHC-P, KO, Simple Western, WB
Species: Hu
Applications: BA
Species: Hu
Applications: CyTOF-ready, ELISA(Cap), ELISA(Det), ELISA(Sta), ICC, ICFlow, Neut, Simple Western, WB
Species: Hu, Mu, Po, Rt
Applications: Flow, IB, ICC/IF, IHC, IHC-Fr, IHC-P, In vitro, WB
Species: Hu
Applications: BA
Species: Hu
Applications: ELISA
Species: Hu, Mu
Applications: Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
Species: Hu
Applications: ELISA
Species: Hu
Applications: CyTOF-ready, ELISA, Flow, ICC/IF, IHC, IHC-P, PA, WB
Species: Hu
Applications: BA
Species: Hu
Applications: ELISA
Species: Hu, Mu, Rt
Applications: IHC, KO, WB
Species: Hu
Applications: Bioactivity
Publications for TNF-alpha (8599-TA) (0)
There are no publications for TNF-alpha (8599-TA).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for TNF-alpha (8599-TA) (0)
There are no reviews for TNF-alpha (8599-TA).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen